Harnessing Real-World Data: The Crucial Role It Plays for Black Communities Beyond Clinical Trials

Real-world data (RWD) is gaining pivotal significance in assessing the efficacy of medications and treatments in daily life, particularly for varied populations like Black communities. This data enriches our understanding by providing insights beyond the confines of clinical trials. In a recent Facebook Live discussion featuring patient advocate Ricki Fairley, Dr. Lynn McRoy, and breast surgeon Dr. Monique Gary, important dialogues emerged on how RWD can be life-saving for Black women. What constitutes Real-World Data? It encompasses health information gathered outside strict clinical trials, sourced from everyday medical practices, which include electronic health records (EHRs), medical claims data, patient registries, and patient-reported outcomes. Addressing underrepresentation, Dr. McRoy from Pfizer asserts that traditional trials often lack diversity. RWD closes this gap, accurately capturing diverse patient experiences, vital for highlighting health disparities. It also provides essential insights into patient-centered care, empowering advocates like Fairley to make informed decisions. Though RWD should not replace randomized controlled trials, it serves as a crucial supplementary tool for equitable healthcare.